Remedy Entertainment Plc | Company announcement 4:40 pm 6 April 2020
Resolutions by Remedy Entertainment Plc’s Annual General Meeting and Board of Directors
Annual General Meeting
Remedy Entertainment Plc’s Annual General Meeting was held in Espoo on 6 April 2020. The meeting approved the financial statements and discharged the members of the Board of Directors and the CEO from liability for the financial period 1 January–31 December 2019.
Dividend
The Annual General Meeting decided a dividend of EUR 0.11 per share, i.e. EUR 1 327 936.50 in the aggregate, to be paid from the financial period that ended on 31 December 2019. The record date for the dividend payment is 8 April 2020 and the payment date is 20 April 2020.
Board of Directors
The Annual General Meeting confirmed that the number of Board members is five. Markus Mäki, Christian Fredrikson, Jussi Laakkonen, Ossi Pohjola and Henri Österlund will continue as members of the Board of Directors.
The Annual General Meeting confirmed that the remuneration payable to the Chairman of the Board of Directors is EUR 3,000 per month and each Board member EUR 2,000 per month.
Auditor
The Annual General Meeting re-elected KPMG Oy Ab as the auditor of the company with APA Petri Sammalisto acting as the auditor with the principal responsibility. The auditor’s fee is paid according to reasonable invoice presented to the company.
Authorization for the directed repurchase of own shares
The Annual General Meeting authorized the Board of Directors to resolve on the directed repurchase of a maximum of 500,000 of the company’s own shares in one or more instalments by using company’s unrestricted equity. The authorization is valid until the closing of the next Annual General Meeting, however, no longer than 6 October 2021 and it replaces the previous authorizations.
Authorization to decide on share issues or issuance of option rights or other special rights
The Annual General Meeting authorized the Board of Directors to resolve on the issuance of shares against payment or issuances of option rights or special rights so that the number of shares to be issued can be at maximum 2,000,000. The issued shares can be new or treasury shares held by the company. Shares can be issued also in deviation from the shareholders’ pre-emptive rights. The authorization is valid for five years from the date of the Annual General Meeting and it replaces the previous authorizations.
Organizing meeting of the Board of Directors
At its organizing meeting held after the Annual General Meeting the Board elected Markus Mäki to continue as the Chairman of the Board of Directors.
Espoo, 6 April 2020
Remedy Entertainment Plc
Board of Directors
MORE INFORMATION
Tero Virtala, CEO
Phone: +358 9 435 5040
Email: tero.virtala@remedygames.com
Lauri Haavisto, Senior Manager, Investor & Talent Relations
Phone: +358 9 435 5040
Email: lauri@remedygames.com
Alexander Corporate Finance Oy, Certified Adviser
Phone: +358 50 520 4098
REMEDY IN BRIEF
Remedy Entertainment Plc is a globally successful video game company known for story-driven and visually stunning console and computer games such as Control, Alan Wake and Max Payne. Remedy also develops its own Northlight game engine and game development tools.
Founded and based in 1995, Finland, the company employs over 260 game industry professionals from 27 different countries. Remedy is listed on the Nasdaq First North Growth Market Finland marketplace.
DISTRIBUTION
Nasdaq Helsinki Ltd
Key media
www.remedygames.com